TechPrecision (TPCS) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
13 Aug, 2026Executive summary
Consolidated revenue for fiscal 2027 Q1 rose 23% year-over-year to $9.1 million, driven by growth at both Ranor and Stadco and improved project fulfillment.
Gross profit increased 36% to $1.4 million, with gross margin improving to 15.4% from 14.0% year-over-year.
Net loss narrowed to $153,000, or $0.02 per share, from $597,000, or $0.06 per share, in the prior year quarter, reflecting higher gross profit and reduced operating losses at Stadco.
EBITDA improved to $651,000 from $239,000 in the prior year quarter, reflecting operational efficiencies.
Strong customer confidence and on-time delivery led to a funded backlog of $52.7 million and $22 million in unfunded orders.
Financial highlights
Consolidated revenue up 23% year-over-year to $9.1 million; gross profit up 36% to $1.4 million.
Operating loss improved to $45,000 from $463,000 in the prior year.
SG&A expenses decreased 3% due to lower professional fees and office costs.
Interest expense fell 21% due to reduced loan balances and lower amortization of debt costs.
Total debt reduced to $5 million from $7 million sequentially; cash balance at quarter-end was $279,000.
Outlook and guidance
On track to meet fiscal 2027 guidance provided in June 2026, with management expecting double-digit revenue and EBITDA growth.
Guidance for FY 2027: Revenue growth of +10% to $35.0M–$37.0M and EBITDA growth of +80% to $3.0M–$4.0M.
Expectation to deliver $52 million backlog over the next one to three fiscal years with gross margin expansion.
Substantial doubt exists about the ability to continue as a going concern due to recurring losses at Stadco, debt covenant violations, and the need to renew or replace the revolver loan by September 15, 2026.
Management is focused on improving Stadco’s profitability, increasing manufacturing utilization, and reducing costs to enhance liquidity.
Latest events from TechPrecision
- FY 2027 guidance targets $35–$37M revenue and $3–$4M EBITDA, nearly doubling EBITDA year-over-year.TPCS
Q4 2026 - Q3 revenue dropped 7% and net loss widened, but backlog and defense sector demand remain strong.TPCS
Q3 2026 - Proxy contest seeks board change due to failed M&A, poor governance, and financial decline.TPCS
Proxy Filing - Shareholders to vote on director elections, auditor ratification, and executive pay, all board-recommended.TPCS
Proxy Filing - Proxy contest highlights Board-backed director slate, incentive plan amendment, and auditor ratification.TPCS
Proxy Filing - Gross margin rose to 14% as losses narrowed, but going concern risk remains.TPCS
Q1 2026 - Net loss widened to $1.5M as higher costs and breakup fee deepened losses; backlog at $41.2M.TPCS
Q1 2025 - Q3 revenue steady, Ranor profits, Stadco losses, $45.5M backlog, liquidity risks persist.TPCS
Q3 2025 - Q2 revenue up 12%, but losses and liquidity risks persist despite strong backlog.TPCS
Q2 2025